Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2017 2
2019 1
2020 1
2021 4
2022 2
2023 5
2024 1
2025 6
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Free PMC article. Clinical Trial.
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.
Amengual J, Gonzalez-Sanchez E, Yáñez-Bartolome M, Sererols-Viñas L, Ravichandra A, Guiton C, Fuste NP, Alay A, Hijazo-Pechero S, Martín-Mur B, Gut M, Esteve-Codina A, Cantos-Cortes A, Espinosa-Sotelo R, Ramos E, Serrano T, Calvo M, Laquente B, Ferrer J, Pons G, Mendez-Lucas A, Dooley S, Ilyas SI, Vallette M, Aoudjehane L, Lequoy M, Fouassier L, Coulouarn C, Affò S, Scheiter A, Calvisi DF, Tian TV, Fabregat I, Vaquero J. Amengual J, et al. Among authors: calvo m. Signal Transduct Target Ther. 2025 Aug 18;10(1):257. doi: 10.1038/s41392-025-02347-z. Signal Transduct Target Ther. 2025. PMID: 40820091 Free PMC article.
Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma.
Espinosa-Sotelo R, Fusté NP, Peñuelas-Haro I, Alay A, Pons G, Almodóvar X, Albaladejo J, Sánchez-Vera I, Bonilla-Amadeo R, Dituri F, Serino G, Ramos E, Serrano T, Calvo M, Martínez-Chantar ML, Giannelli G, Bertran E, Fabregat I. Espinosa-Sotelo R, et al. Among authors: calvo m. Redox Biol. 2023 Sep;65:102818. doi: 10.1016/j.redox.2023.102818. Epub 2023 Jul 13. Redox Biol. 2023. PMID: 37463530 Free PMC article.
New Experimental Mouse Models to Evaluate the Role of Transforming Growth Factor-Beta in Liver Tumorigenesis.
Cantos-Cortes A, Amengual J, Espinosa-Sotelo R, Bertran E, Vaquero J, de Galarreta MR, Molina-Sanchez P, Serrano T, Ramos E, Calvo M, Scialpi R, Dituri F, Giannelli G, Lujambio A, Gonzalez-Sanchez E, Fabregat I. Cantos-Cortes A, et al. Among authors: calvo m. Liver Int. 2025 Oct;45(10):e70351. doi: 10.1111/liv.70351. Liver Int. 2025. PMID: 40928330 Free PMC article.
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.
Fortuny M, da Fonseca LG, Allaire M, Sánchez R, Nault JC, Iavarone M, Ridolfo S, Pascual S, Jimeno R, Calvo M, Rifà R, Sanduzzi-Zamparelli M, Jiménez-Esquivel N, Mouri S, Iñarrairaegui M, Argemi J, Hernaez T, Lorenzo-Barreto JE, Ferrer MT, Coll S, Lamarca Á, Marin JI, Reverter E, López AM, Lue A, Varela M, Matilla A, Fernández J, Reig M. Fortuny M, et al. Among authors: calvo m. Liver Int. 2025 Sep;45(9):e70264. doi: 10.1111/liv.70264. Liver Int. 2025. PMID: 40792692 Free PMC article.
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.
Alsina M, Villacampa G, de Andrea C, Vivancos A, Ponz-Sarvise M, Arrazubi V, Jimenez-Fonseca P, Diez M, Sanz-Garcia E, Martínez E, Guardeño R, Calvo M, Bugés C, Longo F, Navarro V, García-Galea E, Gros A, Ochoa MC, Lopez-Janeiro A, Sanchez-Gregorio S, Herrero C, Labiano I, Vila-Casadesús M, López D, Alexandru R, Muñoz S, Tabernero J, Melero I. Alsina M, et al. Among authors: calvo m. Clin Cancer Res. 2025 Jul 15;31(14):2890-2898. doi: 10.1158/1078-0432.CCR-25-0369. Clin Cancer Res. 2025. PMID: 40388549 Free PMC article. Clinical Trial.
Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHT.
Balsa M, Alonso S, Sánchez L, Bugés C, Layos L, Calvo M, Garsot E, Viciano M, Clavell A, López R, Uchima H, Muñoz R, Muriel R, González B, Mirallas O, Murphy MB, Terán E, Montal R, Fleitas T, Hierro C. Balsa M, et al. Among authors: calvo m. Cancer Treat Rev. 2026 May;146:103141. doi: 10.1016/j.ctrv.2026.103141. Epub 2026 Apr 23. Cancer Treat Rev. 2026. PMID: 42035746 Review.
Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives.
Teixidó Mulet M, Veas Rodriguez J, Terán E, Piñol M, Vilardell F, Iglesias M, Hierro C, Calvo M, Matias-Guiu X, Salud A, Tabernero J, Montal R. Teixidó Mulet M, et al. Among authors: calvo m. Cancer Treat Rev. 2026 Apr;145:103124. doi: 10.1016/j.ctrv.2026.103124. Epub 2026 Mar 26. Cancer Treat Rev. 2026. PMID: 41921305 Free article. Review.
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
Gonzalez-Sanchez E, Vaquero J, Férnandez-Barrena MG, Lasarte JJ, Avila MA, Sarobe P, Reig M, Calvo M, Fabregat I. Gonzalez-Sanchez E, et al. Among authors: calvo m. Cancers (Basel). 2021 Jun 29;13(13):3248. doi: 10.3390/cancers13133248. Cancers (Basel). 2021. PMID: 34209646 Free PMC article. Review.
27 results